Skip to main content
  • Home
  • Charité Center for Rare Diseases
Institutional profile

Charité Center for Rare Diseases

Charité Center for Rare Diseases, the Berliner Centrum für Seltene Erkrankungen (BCSE), was founded in 2011 within Charité. It coordinates specialist referrals and interdisciplinary diagnostic assessment for adults and children with suspected rare diseases or longstanding unexplained conditions. Rare disease care requires multidisciplinary evaluation, advanced diagnostics, genetics, long-term care coordination, and access to research networks, making it particularly suited to a specialist center structure.

  • Highest 2026 tier: Tier II
  • Centers of Excellence
  • 1 ranking category

Overview

Charité Center for Rare Diseases, the Berliner Centrum für Seltene Erkrankungen (BCSE), was founded in 2011 within Charité. It coordinates specialist referrals and interdisciplinary diagnostic assessment for adults and children with suspected rare diseases or longstanding unexplained conditions. Rare disease care requires multidisciplinary evaluation, advanced diagnostics, genetics, long-term care coordination, and access to research networks, making it particularly suited to a specialist center structure.

Charité’s broader academic platform provides the clinical and scientific environment needed for rare disease work. The institution combines university hospitals, medical faculty, research infrastructure, and specialist departments across Berlin, supporting complex diagnostic and therapeutic pathways.

Charité Center for Rare Diseases is included in 1 2026 ranking category. Its highest classification is Tier II. Ranking recognition is category-specific editorial evidence rather than a substitute for independent diligence.

Firm facts

Public identityCharité Center for Rare Diseases
Founded1710
Institution typeCenters of Excellence institution
HeadquartersBerlin, Germany
Primary focusCenters of Excellence
Highest 2026 ranking tierTier II

Principal activities

Charité’s broader academic platform provides the clinical and scientific environment needed for rare disease work. The institution combines university hospitals, medical faculty, research infrastructure, and specialist departments across Berlin, supporting complex diagnostic and therapeutic pathways.

Core capability

Centers of Excellence

Client relevance

Category-specific capability, institutional credibility and the ability to support demanding professional, commercial or patient needs.

Execution and verification

Current service scope, leadership, geographic coverage, legal entities and regulated activities should be confirmed directly.

Sector and mandate coverage

Primary category

Centers of Excellence

Institutional context

Coverage reflects the institution’s role in the ranking categories listed below. Precise services, products, jurisdictions, clinical scope and client eligibility should be verified for each use case.

Market position

Charité’s academic depth, European influence, and disease-focused coordination support its position among established Centers of Excellence.

Charité Center for Rare Diseases is assessed through public institutional information and Ranking News editorial research. Its strongest 2026 result is Tier II.

Competitive context

The relevant peer set varies by category, geography, client segment and mandate. Charité Center for Rare Diseases should be compared on current category-specific capability, senior involvement, evidence of comparable work, operating resilience and any applicable regulatory or clinical permissions.

Comparable institutions are shown for navigation and market context. Inclusion does not imply identical scale, ownership, geographic coverage, service model or regulatory status.

Leadership and governance

Leadership, ownership, governance and senior-team responsibilities may change. Current information should be verified through authoritative institutional sources.

Corporate and public information

The public-facing organization is identified here as Charité Center for Rare Diseases. Contracting entities, regulated affiliates, clinical operations, offices and legal permissions may differ by service and jurisdiction.

Corporate and disclosure information
OrganizationCharité Center for Rare Diseases
HeadquartersBerlin, Germany
Verification noteConfirm legal entity, licenses, offices and engagement terms directly before appointment or use.

Additional published ranking appearances

These entries retain the edition, classification and assessed business name published in the source. Historical entries describe that edition, including businesses whose ownership or name later changed.

Published rankingEdition / tierAssessed business
Top 20 Centers of Excellence 20252025 · Tier IICharité Center for Rare Diseases
Top 20 Centers of Excellence 20242024 · Tier IICharité Center for Rare Diseases
Top 20 Centers of Excellence 20232023 · Tier IICharité Center for Rare Diseases

Rankings and recognition

2026

Tier II

Ranking inclusion and tier classification are editorial determinations. They should be read as category-specific assessments rather than universal league-table positions. The existence or maintenance of this Wiki profile does not influence ranking eligibility, tier or position.

Related Economy analysis

Selected reporting and market analysis from The Economy provides context for the institution’s operating environment:

Sources and data transparency

Official institutional information, where available, is used for current public identity and capabilities. Ranking pages document 2026 category and tier status. Economy articles provide market context rather than institution-specific endorsement.

  1. Healthcare Ranking — Top 30 Centers of Excellence 2026 — 2026 inclusion and tier classification.
  2. The Economy — Healthcare Rankings and the New Economics of Expertise — market context.
  3. The Economy — Healthcare Market Structure Is Opening a New Lane for Specialist Providers — market context.
  4. The Economy — Healthcare Rankings and the New Geography of Distributed Care — market context.

Corrections and Updates

Factual corrections, updated institutional information, and supporting references may be submitted through The Economy Portal. All proposed changes are subject to editorial verification before publication.

First published: 29 August 2026

Last substantively reviewed: 29 August 2026

Profile scope: Centers of Excellence

This profile has been compiled from publicly available institutional and editorial sources. The profiled organization does not determine its inclusion, editorial characterization or ranking status.